PLK3 1-334 T219D-pEGFP Citations (1)

Originally described in: Polo-like kinase 3 functions as a tumor suppressor and is a negative regulator of hypoxia-inducible factor-1 alpha under hypoxic conditions.
Yang Y, Bai J, Shen R, Brown SA, Komissarova E, Huang Y, Jiang N, Alberts GF, Costa M, Lu L, Winkles JA, Dai W Cancer Res. 2008 Jun 1. 68(11):4077-85. PubMed Journal

---

Articles Citing PLK3 1-334 T219D-pEGFP

Articles

Polo-like kinase 3 (PLK3) mediates the clearance of the accumulated PrP mutants transiently expressed in cultured cells and pathogenic PrP(Sc) in prion infected cell line via protein interaction. Wang H, Tian C, Fan XY, Chen LN, Lv Y, Sun J, Zhao YJ, Zhang LB, Wang J, Shi Q, Gao C, Chen C, Shao QX, Dong XP. Int J Biochem Cell Biol. 2015 May;62:24-35. doi: 10.1016/j.biocel.2015.02.011. Epub 2015 Feb 25. PubMed

If you have published an article using this material, please email us at to have your article added to this page.